Myria Biosciences
Basel
About Myria Biosciences
Myria have developed a genetically engineered platform that allows for the discovery of complex natural product molecules which have pharmaceutical applications. They screen tens of millions of compounds for identification and optimisation of drug lead candidates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.9M
- Funding stage: Seed
- Last round: Pre-Seed (Jan 2024)
- Website: myria.bio
- Phone: +41 61 551 03 80
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/myria-biosciences-52135 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.